A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS Topical Product in Patients With Mild to Severe Scalp Psoriasis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 07 May 2017
At a glance
- Drugs Desoximetasone (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 16 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2018.
- 16 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Jan 2018.
- 16 Mar 2017 Status changed from recruiting to active, no longer recruiting.